MIMEDX GROUP INC - COMMON STOCK

Leading Independent Proxy Advisory Firm ISS Recommends that MIMEDX Shareholders Vote “FOR ALL” of the Company’s Proposals

25 май 2022 17:26:30 Источник Nasdaq GlobeNewswire

Leading Independent Proxy Advisory Firm Glass Lewis Recommends that MIMEDX Shareholders Vote “FOR ALL” of the Company’s Proposals

20 май 2022 09:00:00 Источник Nasdaq GlobeNewswire

MIMEDX Investor Presentation Highlights Clear Strategy for Value Creation

18 май 2022 16:18:33 Источник Nasdaq GlobeNewswire

MIMEDX Mails Letter to Shareholders

16 май 2022 08:00:02 Источник Nasdaq GlobeNewswire

MIMEDX Comments on Prescience Point’s False and Misleading Statements

09 май 2022 08:00:02 Источник Nasdaq GlobeNewswire

MIMEDX to Participate at Upcoming Investor Conferences

05 май 2022 08:00:01 Источник Nasdaq GlobeNewswire

MIMEDX Announces First Quarter 2022 Operating and Financial Results

03 май 2022 16:31:59 Источник Nasdaq GlobeNewswire

MIMEDX Comments on Prescience Point’s Recent Filing

29 апр 2022 09:09:47 Источник Nasdaq GlobeNewswire

MIMEDX to Host First Quarter 2022 Operating and Financial Results Conference Call on May 4

20 апр 2022 08:00:01 Источник Nasdaq GlobeNewswire

MIMEDX to Present Health Economics Clinical Data for EPIFIX® in Treatment of Lower Extremity Diabetic Ulcers at SAWC Spring

05 апр 2022 08:00:01 Источник Nasdaq GlobeNewswire

MIMEDX to Present at the Canaccord Genuity Musculoskeletal Conference

15 мар 2022 08:00:01 Источник Nasdaq GlobeNewswire

MIMEDX Announces Fourth Quarter and Full Year 2021 Operating and Financial Results

28 фев 2022 16:06:03 Источник Nasdaq GlobeNewswire

Peer-Reviewed Study Demonstrates Increased Cost-Effectiveness of MIMEDX Dehydrated Human Amnion Chorion Membrane (DHACM) in Lower Extremity Diabetic Ulcer (LEDU) Treatment Compared to Standard of Care

16 фев 2022 08:35:43 Источник Nasdaq GlobeNewswire

MIMEDX to Host Fourth Quarter 2021 Operating and Financial Results Conference Call on February 28

14 фев 2022 08:00:01 Источник Nasdaq GlobeNewswire

MIMEDX Announces Dismissal of Putative Securities Class Action Lawsuit

28 янв 2022 12:40:00 Источник Nasdaq GlobeNewswire

MIMEDX Outlines Key Strategic Milestones for 2022

10 янв 2022 08:00:01 Источник Nasdaq GlobeNewswire

MIMEDX to Participate at the H.C. Wainwright BioConnect Virtual Conference

04 янв 2022 16:05:00 Источник Nasdaq GlobeNewswire

MIMEDX to Present at the 40th Annual J.P. Morgan Healthcare Conference

22 дек 2021 08:00:00 Источник Nasdaq GlobeNewswire

MIMEDX Outlines Long-Term Value Creation Strategy at Virtual Investor Day

07 дек 2021 07:00:01 Источник Nasdaq GlobeNewswire

MIMEDX Announces Speakers for December 7 Investor Day

30 ноя 2021 08:00:01 Источник Nasdaq GlobeNewswire